跳至主要内容
临床试验/NCT01943968
NCT01943968Unknown不适用

Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis

Hillel Yaffe Medical Center1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2013年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Fibrin Enzyme Levels in Blood

研究概览

简要总结

The aim of our study is to find a biomarker for fibrosis or vasculopathy in systemic sclerosis. We will evaluate a possible correlation between semaphorin 7a, semaphorin 3a and lysyl oxidase and fibrosis (lung and skin) or vasculopathy in patients with systemic sclerosis. The results obtained may help us diagnose these complications of systemic sclerosis and hopefully even monitor patient treatment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Systemic Sclerosis Patients
  • Written consent to participation in study

排除标准

  • Serious active medical condition
  • Other autoimmune rheumatic disease
  • Current or past allergic/inflammatory reaction
  • Liver disease
  • Pregnant or breastfeeding
  • Illegal drug or alcohol abuse

结局指标

主要结局

Fibrin Enzyme Levels in Blood

时间窗: Six months

Patients will undergo blood tests before study and after six months to determine levels of lysyl oxidase, semaphorin 7a and 3a and thus determine severity of the disease (systemic sclerosis).

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验